Spain is investigating Novo Nordisk over concerns it may be indirectly marketing its weight loss drugs. Euronews Health spoke ...

Novo Nordisk shares have come under pressure amid weight-loss drug competition, while UK health officials have launched a ...

American Idol star Adam Lambert once explained why he switched from Ozempic to Mounjaro after revealing his drastic weight ...

Access is opening up for Kiwis to a weight loss drug described as a game changer. Wegovy, made by pharma-co Novo Nordisk, ...

People with type 1 diabetes who need to lose weight can benefit from the blockbuster GLP-1 drug semaglutide currently ...

A handful of New York City restaurants have been putting smaller portion sizes on their menus amid the rise of weight-loss ...

The pharmaceutical company alleges Hims is widely selling cheaper versions of its blockbuster drugs, despite the FDA's recent ...

Novo Nordisk continues to expand its partnerships with telehealth companies to broaden access to its blockbuster weight loss ...

Novo Nordisk launches Wegovy, its anti-obesity drug, in India. Targeting a large obese population, Wegovy aims to improve ...

Novo Nordisk's U.S.-listed shares fell close to 6% Monday after the drugmaker revealed the latest results for a new ...

Explore Novo Nordisk's stock price predictions for 2025, 2026 and 2030, driven by the success of Ozempic and its expanding role in diabetes and obesity treatments. My Account Benzinga Edge ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...